B4GALT2 and ovarian carcinoma: B4GALT2, which builds key β1,4-galactosylated structures in N- and O-linked glycans, has demonstrated increased expression in ovarian cancer cells, indicating a role in tumor-associated glycosylation remodeling (41, 42).